Work

Genetic Analysis of Clinical Prostate Cancer

Year: 2005
Type: dissertation
Abstract: The general scope of this thesis is to assess molecular changes in prostate cancer cells. This is \nimportant because of two reasons: 1) knowledge of molecular changes may contribute to the \nunderstanding of prostate cancer development and lead to new therapies and 2) molecular \nchanges may have prognostic value. \n\nDespite large changes in incidence and management of prostate cancer in the past decades, \nprostate cancer mortality has shown only minor changes. A modest drop in mortality is noted \nsince 1992 in the USA [1]. For metastatic disease the corner stone of treatment remains hormonal therapy, originally described by Huggins and Hodges in 1941 [2]. This gives a response \nin most cases but after an average of 18 months hormone refractory disease develops. A \nbetter understanding of the molecular changes underlying prostate cancer is important to \ndevelop new, targeted therapies. \n\nThe incidence of prostate cancer has markedly increased since the introduction of the PSA \nserum test in 1986. Many early cancers develop very slowly, and are clinically not relevant. To \ndate, it is not possible to accurately indicate for which cancers immediate therapy is required. \nIt is estimated that 17 patients have to undergo curative treatment in order to prevent 1 patient from dying of prostate cancer [3]. In a screening population this number is even higher. \nAccurate prognostic factors are urgently needed.
Language: English
Subfield: Cancer Research
Open Access status: green
OpenAlex ID: W1492381033
Cites: 286
Cited by:
Related to: 10